Qdot solubilization and functionalization. (A) Surface chemistries. TOPO (trioctylphosphine oxide)–passivated qdots can be solubilized in aqueous buffer by addition of a layer of amphiphilic molecules containing hydrophilic (w+) and hydrophobic (w–) moieties, or by exchange of TOPO with molecules that have a Zn-coordinating end (usually a thiol group, SH) and a hydrophilic end. Examples of addition include (a) formation of a cross-linked polymer shell (31), (b) coating with a layer of amphiphilic triblock copolymer (26), and (c) encapsulation in phospholipid micelles (29). Examples of exchange include (d) mercaptoacetic acid (MAA) (20), (e) dithiothreitol (DTT) (21), (f) dihydrolipoic acid (DHLA) (33), (g) oligomeric phosphines (22), (h) cross-linked dendrons (23), and (i) peptides (24). The curved arrow indicates sites available for further functionalization. (B) Peptide toolkit. The light blue segment contains cysteines and hydrophobic amino acids ensuring binding to the qdot (24) and is common to all peptides. S, solubilization sequence; P, PEG; B, biotin; R, peptide recognition sequence; Q, quencher; D, DOTA; X, any unspecified peptide-encoded function. Qdot solubilization is obtained by a mixture of S and P. Qdots can be targeted with B, R, or other chemical moieties. Qdot fluorescence can be turned on or off by attaching a Q via a cleavable peptide link. In the presence of the appropriate enzyme, the quencher is separated from the qdot, restoring the photoluminescence and reporting on the enzyme activity. For simultaneous PET and fluorescence imaging, qdots can be rendered radioactive by D chelation of radionuclides; for simultaneous MRI and fluorescence imaging, qdots can be rendered radioactive by D chelation of nuclear spin labels.